[Neuropathies associated with monoclonal IgM anti-MAG antibodies].

No abstract is available for this paper.

• Publication year

  2012

• Venue

  La Revue de medecine interne

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.revmed.2012.05.009PMID 22726239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myelin‐associated glycoprotein protects neurons from excitotoxicity

  2011cited by this paper
• Non‐anti‐MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases

  2011cited by this paper
• Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies

  2011cited by this paper
• B-cell-activating factor in rituximab-treated patients with anti-MAG polyneuropathy

  2010cited by this paper
• European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision

  2010cited by this paper
• [Anti-MAG paraproteinemic demyelinating polyneuropathy: a clinical, biological, electrophysiological and anatomopathological descriptive study of a 13-patients' cohort].

  2009cited by this paper
• Immunoglobulin M Deposition in Cutaneous Nerves of Anti-Myelin-Associated Glycoprotein Polyneuropathy Patients Correlates With Axonal Degeneration

  2009cited by this paper
• Les polyneuropathies avec IgM monoclonale anti-MAG : étude descriptive clinique, biologique, électrophysiologique et anatomopathologique d’une cohorte de 13 patients

  2009cited by this paper
• Placebo‐controlled trial of rituximab in IgM anti–myelin‐associated glycoprotein antibody demyelinating neuropathy

  2009cited by this paper
• Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy

  2009cited by this paper
• [Electron microscopy as a tool for the diagnosis of neuropathies].

  2008cited by this paper
• [Dysimmune peripheral neuropathies: evaluation of treatment].

  2007cited by this paper
• Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.

  2006cited by this paper
• Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy

  2006cited by this paper
• [Diagnostic value of autoantibodies to MAG by ELISA Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG].

  2006cited by this paper
• Anti-myelin-associated glycoprotein neuropathy

  2006cited by this paper
• Differential diagnosis of chronic dysimmune demyelinating polyneuropathies with and without anti‐MAG antibodies

  2005cited by this paper
• Neuropathy associated with “benign” anti-myelin-associated glycoprotein IgM gammopathy: Clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases

  2004cited by this paper
• Distal motor latency and residual latency as sensitive markers of anti-MAG polyneuropathy

  2003cited by this paper
• Connecting impairment, disability, and handicap in immune mediated polyneuropathies

  2003cited by this paper
• Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing.

  2002cited by this paper
• Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?

  2002cited by this paper
• Treatment experience in patients with anti–myelin‐associated glycoprotein neuropathy

  2001cited by this paper
• The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies.

  2001cited by this paper
• La revue de médecine interne

  2000cited by this paper
• Distal acquired demyelinating symmetric neuropathy

  2000cited by this paper
• Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies.

  2000cited by this paper
• Anti‐MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening

  1999cited by this paper
• Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M‐protein antibody activity and clinical/electrophysiological features in 40 cases

  1998cited by this paper
• Blood-nerve barrier in IgM paraproteinemic neuropathy: a clinicopathologic assessment

  1998cited by this paper
• Physiological tremor analysis of patients with anti‐myelin‐associated glycoprotein associated neuropathy and tremor

  1997cited by this paper
• Tremor associated with benign IgM paraproteinaemic neuropathy.

  1996cited by this paper
• Anti‐MAG and anti‐SGPG antibodies in neuropathy

  1996cited by this paper
• Morphological changes at paranodes in IgM paraproteinaemic neuropathy

  1996cited by this paper
• Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance

  1996cited by this paper
• [Anti-glycoconjugate antibodies and dysglobulinemic or dysimmune peripheral neuropathies].

  1996cited by this paper
• Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients.

  1996influential reference
• Motor conduction parameters in neuropathies associated with anti‐mag antibodies and other types of demyelinating and axonal neuropathies

  1995cited by this paper
• Peripheral neuropathy in IgM monoclonal gammopathy and wäldenstrom's macroglobulinemia: A frequent complication in elderly males with low MAG‐reactive serum monoclonal component

  1994cited by this paper
• Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities.

  1994cited by this paper
• Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside.

  1994cited by this paper
• Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies.

  1993cited by this paper
• Polyneuropathy associated with monoclonal gammopathy of undetermined significance

  1993cited by this paper
• Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti‐myelin‐associated glycoprotein

  1993cited by this paper
• Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies

  1992cited by this paper
• The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia

  1991cited by this paper
• Neuropathy associated with monoclonal gammopathies of undetermined significance

  1991cited by this paper
• The electrodiagnostic findings in polyneuropathies associated with IgM monoclonal gammopathies

  1990cited by this paper
• Anti–myelin‐associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia

  1989cited by this paper
• Electrophysiologic study of experimental demyelination induced by serum of patients with IgM M proteins and neuropathy

  1989cited by this paper
• Polyneuropathy associated with IgM monoclonal gammopathy

  1989cited by this paper
• Demyelination induced by intraneural injection of human antimyelin‐associated glycoprotein antibodies

  1988cited by this paper
• Polyneuropathies associated with IgM monoclonal gammopathies.

  1988cited by this paper
• Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti‐MAG IgM M‐protein

  1987cited by this paper
• Peripheral neuropathy in macroglobulinemia

  1987cited by this paper
• Visual evoked potentials in patients with neuropathy and macroglobulinemia

  1987cited by this paper
• [Polyneuropathies with IgM monoclonal gammopathy. 12 cases].

  1987cited by this paper
• Polyneuropathy and IgM monoclonal gammopathy: Studies on the pathogenetic role of anti‐myelin‐associated glycoprotein antibody

  1985cited by this paper
• Microangiopathy of vasa nervorum in dysglobulinemic neuropathy

  1984cited by this paper
• Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia.

  1983cited by this paper
• Prevalence of monoclonal protein in peripheral neuropathy

  1981cited by this paper

• Détermination d’un seuil de positivité en ELISA des anticorps anti-Myelin associated glycoprotein

  2025cites this paper
• Humoral response against myelin associated glycoprotein reflects oligodendroglial degeneration in Parkinson's disease.

  2016cites this paper
• High ultrasound variability in chronic immune-mediated neuropathies. Review of the literature and personal observations.

  2013cites this paper
• Neuropathies associées aux paraprotéinémies (gammapathies monoclonales)

  2013cites this paper